Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures ; volume:38 ; number:1 ; day:13 ; month:6 ; year:2019 ; pages:1-12 ; date:12.2019
Journal of experimental & clinical cancer research ; 38, Heft 1 (13.6.2019), 1-12, 12.2019
- Urheber
-
Corte, Carminia Maria Della
Barra, Giusi
Ciaramella, Vincenza
Liello, Raimondo Di
Vicidomini, Giovanni
Zappavigna, Silvia
Luce, Amalia
Abate, Marianna
Fiorelli, Alfonso
Caraglia, Michele
Santini, Mario
Martinelli, Erika
Troiani, Teresa
Ciardiello, Fortunato
Morgillo, Floriana
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-019-1257-1
- URN
-
urn:nbn:de:101:1-2019112600041568983388
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Corte, Carminia Maria Della
- Barra, Giusi
- Ciaramella, Vincenza
- Liello, Raimondo Di
- Vicidomini, Giovanni
- Zappavigna, Silvia
- Luce, Amalia
- Abate, Marianna
- Fiorelli, Alfonso
- Caraglia, Michele
- Santini, Mario
- Martinelli, Erika
- Troiani, Teresa
- Ciardiello, Fortunato
- Morgillo, Floriana
- SpringerLink (Online service)
Ähnliche Objekte (12)
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC
Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression
The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway
Antitumor effect and molecular mechanism of fucoidan in NSCLC
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
MEK
MEK
MEK
..mek
Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1
BRAF/MEK-targeted therapy in BRAF ex15 p.T599dup mutation-driven NSCLC: a case report
Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC
Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression
The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway
Antitumor effect and molecular mechanism of fucoidan in NSCLC
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
MEK
MEK
MEK
..mek
Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1
BRAF/MEK-targeted therapy in BRAF ex15 p.T599dup mutation-driven NSCLC: a case report
Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC
Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression
The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway
Antitumor effect and molecular mechanism of fucoidan in NSCLC
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
MEK
MEK
MEK
..mek
Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1
BRAF/MEK-targeted therapy in BRAF ex15 p.T599dup mutation-driven NSCLC: a case report